Interruption of pregnancy by PGF2 alpha. I. Intraamniotic administration. 1972

F E Szontágh, and E Szabó, and A Tekulics, and I Kovács

UI MeSH Term Description Entries
D006982 Hypertonic Solutions Solutions that have a greater osmotic pressure than a reference solution such as blood, plasma, or interstitial fluid. Hypertonic Solution,Solution, Hypertonic,Solutions, Hypertonic
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011262 Pregnancy Trimester, Second The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Midtrimester,Pregnancy, Second Trimester,Trimester, Second,Midtrimesters,Pregnancies, Second Trimester,Pregnancy Trimesters, Second,Second Pregnancy Trimester,Second Pregnancy Trimesters,Second Trimester,Second Trimester Pregnancies,Second Trimester Pregnancy,Second Trimesters,Trimesters, Second
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F E Szontágh, and E Szabó, and A Tekulics, and I Kovács
December 1978, Contraception,
F E Szontágh, and E Szabó, and A Tekulics, and I Kovács
January 1986, Acta chirurgica Hungarica,
F E Szontágh, and E Szabó, and A Tekulics, and I Kovács
June 1974, Orvosi hetilap,
F E Szontágh, and E Szabó, and A Tekulics, and I Kovács
March 1973, Acta Europaea fertilitatis,
F E Szontágh, and E Szabó, and A Tekulics, and I Kovács
October 1985, The Journal of reproductive medicine,
F E Szontágh, and E Szabó, and A Tekulics, and I Kovács
January 1983, Journal de gynecologie, obstetrique et biologie de la reproduction,
F E Szontágh, and E Szabó, and A Tekulics, and I Kovács
July 1980, Obstetrics and gynecology,
F E Szontágh, and E Szabó, and A Tekulics, and I Kovács
July 1983, Orvosi hetilap,
F E Szontágh, and E Szabó, and A Tekulics, and I Kovács
June 1975, Sovetskaia meditsina,
F E Szontágh, and E Szabó, and A Tekulics, and I Kovács
May 1972, Zeitschrift fur Krankenpflege. Revue suisse des infirmieres,
Copied contents to your clipboard!